Hepatology
Signal score, how each part rates
ActionabilityPrevalenceStakesEvidence strengthNovelty
See the full rubric →Erythrocyte phosphatidylserine externalization shows greater discriminatory performance than red cell distribution width for early recurrence or progression in hepatocellular carcinoma.
Clinical takeawayNo clinical action yet: a mechanistic finding in humans with preclinical validation in mice and cell culture.
What it foundPhosphatidylserine (PS) externalization had higher discriminatory performance for 6-month HCC recurrence/progression than RDW-CV (AUC 0.804 vs 0.642).
ContextChallenges the role of RDW as a biomarker in HCC by proposing PS externalization as a superior marker for early recurrence/progression.
No standard claimed for this paper
Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.
Tan M … Huang H · Journal of Gastroenterology · IF 5.7 · PubMed ↗